Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis.

by Johannes Brettschneider, Jon B Toledo, Vivianna M Van Deerlin, Lauren Elman, Leo McCluskey, Virginia M-Y Lee, John Q Trojanowski
Published 2012-01-01

High beta activity in the subthalamic nucleus and freezing of gait in Parkinson's disease

by Jon B. Toledo, Jon López-Azcárate, David Garcia-Garcia, Jorge Guridi, Miguel Valencia, Julio Artieda, Jose Obeso, Manuel Alegre, Maria Rodriguez-Oroz
Published 2014-04-01

Relationship between plasma analytes and SPARE-AD defined brain atrophy patterns in ADNI.

by Jon B Toledo, Xiao Da, Priyanka Bhatt, David A Wolk, Steven E Arnold, Leslie M Shaw, John Q Trojanowski, Christos Davatzikos, Alzheimer’s Disease Neuroimaging Initiative
Published 2013-01-01

Integration and relative value of biomarkers for prediction of MCI to AD progression: Spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers

by Xiao Da, Jon B. Toledo, Jarcy Zee, David A. Wolk, Sharon X. Xie, Yangming Ou, Amanda Shacklett, Paraskevi Parmpi, Leslie Shaw, John Q. Trojanowski, Christos Davatzikos
Published 2014-01-01

Regional tract‐specific white matter hyperintensities are associated with patterns of aging‐related brain atrophy via vascular risk factors, but also independently

by Mohamad Habes, Guray Erus, Jon B. Toledo, Nick Bryan, Deborah Janowitz, Jimit Doshi, Henry Völzke, Ulf Schminke, Wolfgang Hoffmann, Hans J. Grabe, David A. Wolk, Christos Davatzikos
Published 2018-01-01

Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases

by Kira S. Sheinerman, Jon B. Toledo, Vladimir G. Tsivinsky, David Irwin, Murray Grossman, Daniel Weintraub, Howard I. Hurtig, Alice Chen-Plotkin, David A. Wolk, Leo F. McCluskey, Lauren B. Elman, John Q. Trojanowski, Samuil R. Umansky
Published 2017-11-01

Influence of genetic variation on plasma protein levels in older adults using a multi-analyte panel.

by Sungeun Kim, Shanker Swaminathan, Mark Inlow, Shannon L Risacher, Kwangsik Nho, Li Shen, Tatiana M Foroud, Ronald C Petersen, Paul S Aisen, Holly Soares, Jon B Toledo, Leslie M Shaw, John Q Trojanowski, Michael W Weiner, Brenna C McDonald, Martin R Farlow, Bernardino Ghetti, Andrew J Saykin, Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Published 2013-01-01

Identifying amyloid pathology–related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study

by Yuk Yee Leung, Jon B. Toledo, Alexey Nefedov, Robi Polikar, Nandini Raghavan, Sharon X. Xie, Michael Farnum, Tim Schultz, Young Baek, Vivianna M. Van Deerlin, William T. Hu, David M. Holtzman, Anne M. Fagan, Richard J. Perrin, Murray Grossman, Holly D. Soares, Mitchel A. Kling, Matthew Mailman, Steven E. Arnold, Vaibhav A. Narayan, Virginia M‐Y. Lee, Leslie M. Shaw, David Baker, Gayle M. Wittenberg, John Q. Trojanowski, Li‐San Wang, Alzheimer's Disease Neuroimaging Initiative
Published 2015-09-01

Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome

by Matthias Arnold, Kwangsik Nho, Alexandra Kueider-Paisley, Tyler Massaro, Kevin Huynh, Barbara Brauner, Siamak MahmoudianDehkordi, Gregory Louie, M. Arthur Moseley, J. Will Thompson, Lisa St John-Williams, Jessica D. Tenenbaum, Colette Blach, Rui Chang, Roberta D. Brinton, Rebecca Baillie, Xianlin Han, John Q. Trojanowski, Leslie M. Shaw, Ralph Martins, Michael W. Weiner, Eugenia Trushina, Jon B. Toledo, Peter J. Meikle, David A. Bennett, Jan Krumsiek, P. Murali Doraiswamy, Andrew J. Saykin, Rima Kaddurah-Daouk, Gabi Kastenmüller
Published 2020-03-01